JBM (Healthcare) Limited (HKG:2161)
2.390
0.00 (0.00%)
Jun 1, 2026, 3:59 PM HKT
JBM (Healthcare) Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 1,953 | 1,457 | 790 | 987 | 813 | 1,198 | |
Market Cap Growth | 7.61% | 84.51% | -19.97% | 21.34% | -32.09% | - |
Enterprise Value | 2,150 | 1,411 | 836 | 1,112 | 1,033 | 1,446 |
Last Close Price | 2.39 | 1.67 | 0.82 | 0.88 | 0.74 | 1.09 |
PE Ratio | 9.71 | 7.39 | 6.05 | 17.28 | 33.03 | 52.99 |
PS Ratio | 2.40 | 1.86 | 1.22 | 1.90 | 2.00 | 3.02 |
PB Ratio | 1.73 | 1.25 | 0.77 | 0.96 | 0.84 | 1.26 |
P/TBV Ratio | 34.06 | 5.50 | 5.99 | 7.73 | 8.10 | 22.61 |
P/FCF Ratio | 12.31 | 7.08 | 4.36 | 7.18 | 15.36 | 33.45 |
P/OCF Ratio | 10.35 | 6.42 | 4.13 | 6.78 | 13.56 | 20.38 |
EV/Sales Ratio | 2.64 | 1.80 | 1.29 | 2.14 | 2.55 | 3.64 |
EV/EBITDA Ratio | 6.73 | 5.21 | 4.28 | 11.01 | 13.80 | 13.76 |
EV/EBIT Ratio | 8.08 | 6.04 | 5.16 | 15.77 | 25.02 | 19.70 |
EV/FCF Ratio | 13.55 | 6.85 | 4.62 | 8.09 | 19.52 | 40.38 |
Debt / Equity Ratio | 0.33 | 0.15 | 0.13 | 0.18 | 0.22 | 0.28 |
Debt / EBITDA Ratio | 1.17 | 0.60 | 0.64 | 1.58 | 2.39 | 2.29 |
Debt / FCF Ratio | 2.36 | 0.83 | 0.74 | 1.31 | 4.03 | 7.48 |
Net Debt / Equity Ratio | 0.12 | -0.05 | -0.03 | 0.02 | 0.14 | 0.18 |
Net Debt / EBITDA Ratio | 0.45 | -0.23 | -0.17 | 0.17 | 1.79 | 1.59 |
Net Debt / FCF Ratio | 0.86 | -0.30 | -0.19 | 0.12 | 2.53 | 4.66 |
Asset Turnover | 0.51 | 0.53 | 0.47 | 0.38 | 0.30 | 0.29 |
Inventory Turnover | 3.76 | 4.24 | 4.25 | 6.15 | 5.10 | 3.56 |
Quick Ratio | 2.41 | 1.32 | 1.25 | 1.42 | 1.69 | 1.72 |
Current Ratio | 2.91 | 1.61 | 1.66 | 1.70 | 2.06 | 2.07 |
Return on Equity (ROE) | 20.38% | 18.55% | 13.37% | 6.33% | 2.44% | 3.69% |
Return on Assets (ROA) | 10.43% | 9.95% | 7.26% | 3.22% | 1.90% | 3.34% |
Return on Invested Capital (ROIC) | 17.36% | 18.75% | 13.26% | 5.40% | 2.83% | 4.89% |
Return on Capital Employed (ROCE) | 16.70% | 18.50% | 13.90% | 5.80% | 3.40% | 5.90% |
Earnings Yield | 11.08% | 13.54% | 16.52% | 5.79% | 3.03% | 1.89% |
FCF Yield | 8.12% | 14.13% | 22.92% | 13.93% | 6.51% | 2.99% |
Dividend Yield | 8.16% | 10.20% | 9.12% | 3.40% | - | - |
Payout Ratio | 64.27% | 39.89% | 40.41% | 7.83% | - | - |
Buyback Yield / Dilution | -4.46% | - | 0.86% | 0.26% | -9.79% | -12.74% |
Total Shareholder Return | 3.70% | 10.20% | 9.98% | 3.65% | -9.79% | -12.74% |